Enhanced recovery after surgery is feasible and safe in liver transplantation: a cohort study

HPB (Oxford). 2022 Nov;24(11):2022-2028. doi: 10.1016/j.hpb.2022.07.010. Epub 2022 Jul 20.

Abstract

Background: The principles of enhanced recovery after surgery (ERAS) are being applied to still more advanced procedures. Liver transplantation offers a unique opportunity for a multimodal approach including donor care as well. Our objective was to determine if ERAS was applicable and safe in orthotopic liver transplantation (OLT).

Methods: A national single centre retrospective study showing the implementation of ERAS from 2013 to 2019 with the proceeding 2 years serving as baseline. The primary endpoints were mortality, length of stay (LOS) in the ward and intensive care unit stay. Secondary endpoints were complications estimated by Dindo-Clavien classification, comprehensive complication index (CCI®) and re-admissions.

Results: A total of 334 patients were included. LOS was significantly reduced from a median of 22.5 days at introduction to 14 days at 2019. Cold ischaemia time was reduced from a mean of 10.7 to 6.0 h and the use of blood products (erythrocytes, plasma and thrombocytes) from a median of 28 to 6 units. Complications were reduced in severity. Mortality and readmission rates were not affected.

Conclusion: ERAS principles are safe and recommended in patients undergoing OLT resulting in reduced severity of complications and LOS without affecting re-admissions or mortality.

MeSH terms

  • Cohort Studies
  • Enhanced Recovery After Surgery*
  • Humans
  • Length of Stay
  • Liver Transplantation* / adverse effects
  • Postoperative Complications / etiology
  • Retrospective Studies